In this case,looking for efficacy as well as tox,w
Post# of 72440
In this case,looking for efficacy as well as tox,with major indicators "visible" so close to the initial dosing it will be hard to separate the two.
In that case I see dosing as a catalyst.Also because some "fence sitters" won't believe the trials are starting until they actually "start".
Kelt